Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Isopropyl Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL5858313 | 0.95 | ALDH1A1 (0.55) | — | |
| Isopropyl Alcohol SCHEMBL2167550 | 0.95 | ALDH1A1 (0.55) | — | |
| Isopropyl Alcohol SCHEMBL7671116 | 0.95 | ALDH1A1 (0.67) | — | |
| Isopropyl Alcohol SCHEMBL52447 | 0.95 | — | — | |
| Isopropyl Alcohol SCHEMBL27497569 | 0.95 | ALDH1A1 (0.67) | — | |
| Isopropyl Alcohol SCHEMBL5999087 | 0.95 | ALDH1A1 (0.67) | — | |
| Isopropyl Alcohol SCHEMBL1150321 | 0.90 | — | — | |
| Isopropyl Alcohol SCHEMBL4337774 | 0.90 | ALDH1A1 (0.60) | — | |
| Isopropyl Alcohol SCHEMBL28460723 | 0.88 | ALDH1A1 (0.50) | — | |
| Isopropyl Alcohol SCHEMBL10462689 | 0.84 | ALDH1A1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0691852-B1 | VALPROIC ACID COVALENTLY BONDED TO A LYSOPHOSPHOLIPID | DPHARM LTD (IL) | 2004-02-18 | — | — | EP | disclosed |
| US-6413949-B1 | EPILEPSY THERAPY; VALPROIC ACID ADDUCT | D-PHARM, LTD. (IL) | 2002-07-02 | — | — | US | disclosed |
| US-6355629-B2 | INTRACELLULAR TRANSPORTING ADJUVANT | D-PHARM LTD. (IL) | 2002-03-12 | — | — | US | disclosed |
| US-20010007865-A1 | Prodrugs with enhanced penetration into cells | D-PHARM LTD. (IL) | 2001-07-12 | — | — | US | disclosed |
| US-6166089-A | Prodrugs with enhanced penetration into cells | D-PHARM, LTD. (IL) | 2000-12-26 | — | — | US | disclosed |
| US-6136796-A | DRUGS FOR ANTIISCHEMIC AGENTS, STROKES, ANTIEPILEPTIC AGENTS AND ANTIASTHMA AGENTS | D-PHARM, LTD. (IL) | 2000-10-24 | — | — | US | disclosed |
| US-6077837-A | ADMINISTERING PRODRUG TO MAMMAL COMPRISING PROTEIN KINASE INHIBITOR COVALENTLY BONDED TO TRANSPORTING ADJUVANT, THE COVALENT BOND BEING CLEAVED IN PRESENCE OF SUPERNORMAL ENZYME ACTIVITY TO TREAT CONDITIONS LIKE STROKE, EPILEPSY, ASTHMA | D-PHARM LTD. (IL) | 2000-06-20 | — | — | US | disclosed |
| US-5985854-A | TREATING LOCALIZED TISSUE ISCHEMIA, STROKE, EPILEPSY, ASTHMA AND ALLERGY IN A MAMMAL BY ADMINISTERING PHARMACEUTICALLY ACCEPTABLE PRODRUG COMPRISING A PHARMACOLOGICALLY ACTIVE CARBOXYLIC ACID COVALENTLY BONDED TO INTRACELLULAR | D-PHARM, LTD. (IL) | 1999-11-16 | — | — | US | disclosed |
| EP-0691852-A1 | PRODRUGS WITH ENHANCED PENETRATION INTO CELLS | D-PHARM, LTD. (IL) | 1996-01-17 | — | — | EP | disclosed |
| WO-1994022483-A2 | PRODRUGS WITH ENHANCED PENETRATION INTO CELLS | D-PHARM, LTD. (IL) | 1994-10-13 | — | — | WO | disclosed |
| US-4548923-A | IMMUNOSTIMULANTS, BACTERICIDES, VIRICIDES | CIBA GEIGY CORPORATION (US) | 1985-10-22 | — | — | US | disclosed |
| US-4161521-A | Somatostatin analogs | MERCK & CO., INC. (US) | 1979-07-17 | — | — | US | disclosed |